Nakatsuka Atsuhiro, Yamakado Koichiro, Maeda Masayuki, Yasuda Masayo, Akeboshi Masao, Takaki Haruyuki, Hamada Ayumi, Takeda Kan
Department of Radiology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
J Vasc Interv Radiol. 2004 Jul;15(7):707-12. doi: 10.1097/01.rvi.0000133507.40193.e4.
To evaluate the feasibility, safety, and effectiveness of combined treatment with radiofrequency (RF) ablation followed by bone cement injection in patients with malignant bone neoplasms.
Seventeen patients with 23 bone tumors were treated. The tumors, measuring 1.2-15 cm (mean, 4.9 +/- 3.5 cm), were located in the spine (n = 17), iliac bone (n = 3), sacrum (n = 2), and ischial bone (n = 1). All procedures were performed with computed tomographic (CT) fluoroscopic guidance. An electrode with an internally cooled tip was placed in the bone tumor through a biopsy needle and RF energy was applied, followed by cement injection. Pain relief was evaluated with use of the visual analogue scale score (VAS score). Local therapeutic effects were evaluated by contrast-enhanced MR imaging. Lack of tumor enhancement was considered to indicate necrosis.
The procedures were technically successful in all patients except for one patient with an osteoblastic ischial lesion (22 of 23 patients; 96%). Pain was relieved within 1 week in all 13 patients who reported pain (13 of 13 patients; 100%), with a significant decrease in the VAS score from 8.4 to 1.1 (P <.001). Tumor necrosis was observed in 71% +/- 24% of the tumor volume (range, 14%-100%). Neural damage occurred in four patients in whom the tumor had invaded the posterior cortex of the vertebral body and pedicle.
The combined therapy described here is both feasible and useful for the treatment of malignant bone neoplasms. The safety of the procedure depends on the tumor location. When the tumor is adjacent to the spinal cord, there is a risk of nerve injury.
评估射频(RF)消融联合骨水泥注射治疗恶性骨肿瘤患者的可行性、安全性和有效性。
对17例患有23处骨肿瘤的患者进行了治疗。肿瘤大小为1.2 - 15厘米(平均4.9±3.5厘米),位于脊柱(n = 17)、髂骨(n = 3)、骶骨(n = 2)和坐骨(n = 1)。所有操作均在计算机断层扫描(CT)透视引导下进行。将带有内部冷却尖端的电极通过活检针插入骨肿瘤内,施加射频能量,随后注射骨水泥。使用视觉模拟量表评分(VAS评分)评估疼痛缓解情况。通过对比增强磁共振成像评估局部治疗效果。肿瘤无强化被认为提示坏死。
除1例成骨性坐骨病变患者外,所有患者的操作在技术上均获成功(23例患者中的22例;96%)。所有报告疼痛的13例患者(13例患者中的13例;100%)在1周内疼痛得到缓解,VAS评分从8.4显著降至1.1(P <.001)。观察到肿瘤坏死体积为71%±24%(范围为14% - 100%)。4例肿瘤侵犯椎体后皮质和椎弓根的患者发生了神经损伤。
本文所述的联合治疗对于恶性骨肿瘤的治疗既可行又有效。该操作的安全性取决于肿瘤位置。当肿瘤邻近脊髓时,存在神经损伤的风险。